Characterization of multi-drug tolerant persister cells in Streptococcus suis

Jörg Willenborg1, Daniela Willms, Ralph Bertram

  • 1Institute of Microbiology, University of Veterinary Medicine, Hannover, Germany. joerg.willenborg@tiho-hannover.de.

BMC Microbiology
|June 3, 2014
PubMed
Abstract

Insights

This study identifies multi-drug tolerant persister cells in Streptococcus suis, a zoonotic pathogen. These dormant cells, crucial for bacterial survival, are linked to metabolic pathways and vary with growth phase.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Antimicrobial Tolerance

Background:

  • Persister cells are dormant, non-growing subpopulations exhibiting high tolerance to antibiotics.
  • This 'bet-hedging' strategy is vital for microbial survival, especially in pathogenic bacteria.
  • Understanding persister cells is key to combating persistent infections.

Purpose of the Study:

  • To investigate the formation and characteristics of persister cells in the zoonotic pathogen Streptococcus suis.
  • To determine the influence of growth phase on persister cell development in S. suis.
  • To explore the genetic and metabolic underpinnings of persister cell formation in S. suis.

Main Methods:

  • Culturing Streptococcus suis under varying growth conditions (exponential vs. stationary phase).
  • Assessing multi-drug tolerance of identified persister cells against various antibiotics.
  • Analyzing gene expression related to metabolic pathways in persister cell mutants.
  • Testing for persister cell formation in other S. suis strains and related streptococcal species.

Main Results:

  • Streptococcus suis forms multi-drug tolerant persister cells, with higher numbers observed in stationary phase cultures.
  • S. suis persister cells exhibit significant tolerance to a range of antibiotics, a trait not heritable through multiple passages.
  • A mutation in the arginine deiminase system (involved in metabolic pathways) increased persister cell numbers.
  • Persister cell formation was confirmed in other S. suis strains and pathogenic streptococci.

Conclusions:

  • This study provides the first evidence of multi-drug tolerant persister cells in the zoonotic pathogen Streptococcus suis.
  • Persister cell formation in S. suis is influenced by growth phase and potentially linked to metabolic regulation.
  • The findings suggest persister cells are a conserved phenomenon in pathogenic streptococci, impacting treatment strategies.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
215
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
77
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
526